{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["anxiety and depression", "cancer survivors", "chemotherapy-induced neuropathy", "chemotherapy-induced side effects", "health-related quality of life", "ozone therapy", "pain", "radiation-induced side effects"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "36674232", "DateCompleted": {"Year": "2023", "Month": "01", "Day": "24"}, "DateRevised": {"Year": "2023", "Month": "03", "Day": "29"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2023", "Month": "01", "Day": "13"}], "ELocationID": ["1479", "10.3390/ijerph20021479"], "Journal": {"ISSN": "1660-4601", "JournalIssue": {"Volume": "20", "Issue": "2", "PubDate": {"Year": "2023", "Month": "Jan", "Day": "13"}}, "Title": "International journal of environmental research and public health", "ISOAbbreviation": "Int J Environ Res Public Health"}, "ArticleTitle": "Effects of Ozone Treatment on Health-Related Quality of Life and Toxicity Induced by Radiotherapy and Chemotherapy in Symptomatic Cancer Survivors.", "Abstract": {"AbstractText": ["(1) Background: The continuous improvement in cancer treatment has led to improvement in patients\u2019 survival and a subsequent increase in the number of cancer survivors living with adverse side effects of cancer treatments, sometimes with a high and adverse impact on their health-related quality of life (HRQOL). Side effects of cancer treatments are frequently associated with chronic status of oxidative stress, inflammation, and/or ischemia. The potential for ozone treatment to modulate those processes and improve some of those adverse effects has previously been described. The aim of this study was to evaluate the effect of ozone treatment on the HRQOL and grade of toxicity in symptomatic cancer survivors. (2) Methods: Before and after ozone treatment, we assessed (i) the HRQOL (according to the EQ-5D-5L questionnaire) and (ii) the grade of toxicity (according to the Common Terminology Criteria for Adverse Events of the National Cancer Institute of EEUU (CTCAE v.5.0)) in 26 cancer survivors with chronic side effects of radiotherapy and chemotherapy. (3) Results: There was a significant (p < 0.001) improvement in the EQ-5D-5L index as per the self-reported outcome evaluation of patients\u2019 health status. All the dimensions of the EQ-5D-5L questionnaire (mobility, self-care, activities, pain/discomfort, and anxiety/depression) and the self-evaluation of the health status using the visual analog scale were significantly improved (p < 0.05). The grade of toxicity was also significantly decreased (p < 0.001). (4) Conclusions: In cancer survivors with chronic side effects of cancer treatment, ozone treatment can improve the grade of toxicity and the HRQOL. These results merit additional research. Further studies are ongoing."]}, "AuthorList": [{"Identifier": ["0000-0003-2522-1064"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Unit, Hospital Universitario de Gran Canaria Dr. Negr\u00edn, 35019 Las Palmas de Gran Canaria, Spain."}, {"Identifier": [], "Affiliation": "Chronic Pain Unit, Dr. Negr\u00edn University Hospital, 35019 Las Palmas de Gran Canaria, Spain."}, {"Identifier": [], "Affiliation": "Radiation Oncology Department, Hospital Universitario Dr. Negr\u00edn, 35019 Las Palmas de Gran Canaria, Spain."}, {"Identifier": [], "Affiliation": "Fundaci\u00f3n Canaria Instituto de Investigaci\u00f3n Sanitaria de Canarias (FIISC), 35019 Las Palmas de Gran Canaria, Spain."}, {"Identifier": [], "Affiliation": "Universitary Institute for Research in Biomedicine and Health (iUIBS), Molecular and Translational Pharmacology Group, University of Las Palmas de Gran Canaria, 35016 Las Palmas de Gran Canaria, Spain."}, {"Identifier": [], "Affiliation": "Instituto Universitario de Enfermedades Tropicales y Salud P\u00fablica de Canarias, Universidad de La Laguna, 38296 La Laguna, Spain."}, {"Identifier": [], "Affiliation": "CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 28029 Madrid, Spain."}, {"Identifier": [], "Affiliation": "Spanish Group of Clinical Research in Radiation Oncology (GICOR), 28290 Madrid, Spain."}], "LastName": "Clavo", "ForeName": "Bernardino", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Unit, Hospital Universitario de Gran Canaria Dr. Negr\u00edn, 35019 Las Palmas de Gran Canaria, Spain."}, {"Identifier": [], "Affiliation": "Chronic Pain Unit, Dr. Negr\u00edn University Hospital, 35019 Las Palmas de Gran Canaria, Spain."}, {"Identifier": [], "Affiliation": "Fundaci\u00f3n Canaria Instituto de Investigaci\u00f3n Sanitaria de Canarias (FIISC), 35019 Las Palmas de Gran Canaria, Spain."}], "LastName": "C\u00e1novas-Molina", "ForeName": "Angeles", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Fundaci\u00f3n Canaria Instituto de Investigaci\u00f3n Sanitaria de Canarias (FIISC), 35019 Las Palmas de Gran Canaria, Spain."}, {"Identifier": [], "Affiliation": "Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), Instituto de Salud Carlos III, 28029 Madrid, Spain."}, {"Identifier": [], "Affiliation": "Servicio de Evaluaci\u00f3n y Planificaci\u00f3n del Servicio Canario de Salud (SESCS), 38109 Santa Cruz de Tenerife, Spain."}, {"Identifier": [], "Affiliation": "Instituto de Tecnolog\u00edas Biom\u00e9dicas (ITB), Universidad de la Laguna, 38296 La Laguna, Spain."}], "LastName": "Ramallo-Fari\u00f1a", "ForeName": "Yolanda", "Initials": "Y"}, {"Identifier": ["0000-0002-6184-9070"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Radiation Oncology Department, Hospital Universitario Dr. Negr\u00edn, 35019 Las Palmas de Gran Canaria, Spain."}], "LastName": "Federico", "ForeName": "Mario", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Oncology Department, Complejo Hospitalario Universitario Insular Materno-Infantil de Gran Canaria, 35016 Las Palmas de Gran Canaria, Spain."}], "LastName": "Rodr\u00edguez-Abreu", "ForeName": "Delvys", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Oncology Department, Hospital Universitario de Gran Canaria Dr. Negr\u00edn, 35019 Las Palmas de Gran Canaria, Spain."}], "LastName": "Galv\u00e1n", "ForeName": "Saray", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Radiation Oncology Department, Hospital Universitario Dr. Negr\u00edn, 35019 Las Palmas de Gran Canaria, Spain."}], "LastName": "Ribeiro", "ForeName": "Ivone", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Unit, Hospital Universitario de Gran Canaria Dr. Negr\u00edn, 35019 Las Palmas de Gran Canaria, Spain."}, {"Identifier": [], "Affiliation": "Chronic Pain Unit, Dr. Negr\u00edn University Hospital, 35019 Las Palmas de Gran Canaria, Spain."}], "LastName": "Marques da Silva", "ForeName": "Susana C", "Initials": "SC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chronic Pain Unit, Dr. Negr\u00edn University Hospital, 35019 Las Palmas de Gran Canaria, Spain."}], "LastName": "Navarro", "ForeName": "Minerva", "Initials": "M"}, {"Identifier": ["0000-0002-8057-4279"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Unit, Hospital Universitario de Gran Canaria Dr. Negr\u00edn, 35019 Las Palmas de Gran Canaria, Spain."}], "LastName": "Gonz\u00e1lez-Beltr\u00e1n", "ForeName": "Dami\u00e1n", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Psychiatry Department, Hospital Universitario de Gran Canaria Dr. Negr\u00edn, 35019 Las Palmas de Gran Canaria, Spain."}], "LastName": "D\u00edaz-Garrido", "ForeName": "Juan A", "Initials": "JA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Unit, Hospital Universitario de Gran Canaria Dr. Negr\u00edn, 35019 Las Palmas de Gran Canaria, Spain."}, {"Identifier": [], "Affiliation": "Universidad de La Laguna, 38296 La Laguna, Spain."}], "LastName": "Cazorla-Rivero", "ForeName": "Sara", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Unit, Hospital Universitario de Gran Canaria Dr. Negr\u00edn, 35019 Las Palmas de Gran Canaria, Spain."}, {"Identifier": [], "Affiliation": "Fundaci\u00f3n Canaria Instituto de Investigaci\u00f3n Sanitaria de Canarias (FIISC), 35019 Las Palmas de Gran Canaria, Spain."}, {"Identifier": [], "Affiliation": "Instituto Universitario de Enfermedades Tropicales y Salud P\u00fablica de Canarias, Universidad de La Laguna, 38296 La Laguna, Spain."}, {"Identifier": [], "Affiliation": "CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 28029 Madrid, Spain."}], "LastName": "Rodr\u00edguez-Esparrag\u00f3n", "ForeName": "Francisco", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), Instituto de Salud Carlos III, 28029 Madrid, Spain."}, {"Identifier": [], "Affiliation": "Servicio de Evaluaci\u00f3n y Planificaci\u00f3n del Servicio Canario de Salud (SESCS), 38109 Santa Cruz de Tenerife, Spain."}, {"Identifier": [], "Affiliation": "Instituto de Tecnolog\u00edas Biom\u00e9dicas (ITB), Universidad de la Laguna, 38296 La Laguna, Spain."}], "LastName": "Serrano-Aguilar", "ForeName": "Pedro", "Initials": "P"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Environ Res Public Health", "NlmUniqueID": "101238455", "ISSNLinking": "1660-4601"}, "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Quality of Life"}, {"QualifierName": [], "DescriptorName": "Cancer Survivors"}, {"QualifierName": [], "DescriptorName": "Cross-Sectional Studies"}, {"QualifierName": [], "DescriptorName": "Health Status"}, {"QualifierName": [], "DescriptorName": "Surveys and Questionnaires"}, {"QualifierName": [], "DescriptorName": "Neoplasms"}], "CoiStatement": "The authors declare no other conflicts of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Paice J.A., Portenoy R., Lacchetti C., Campbell T., Cheville A., Citron M., Constine L.S., Cooper A., Glare P., Keefe F., et al. Management of Chronic Pain in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline. J. Clin. Oncol. 2016;34:3325\u20133345. doi: 10.1200/JCO.2016.68.5206.", "ArticleIdList": ["10.1200/JCO.2016.68.5206", "27458286"]}, {"Citation": "Zaj\u0105czkowska R., Kocot-K\u0119pska M., Leppert W., Wrzosek A., Mika J., Wordliczek J. Mechanisms of Chemotherapy-Induced Peripheral Neuropathy. Int. J. Mol. Sci. 2019;20:1451. doi: 10.3390/ijms20061451.", "ArticleIdList": ["10.3390/ijms20061451", "PMC6471666", "30909387"]}, {"Citation": "Seretny M., Currie G.L., Sena E.S., Ramnarine S., Grant R., MacLeod M.R., Colvin L.A., Fallon M. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis. Pain. 2014;155:2461\u20132470. doi: 10.1016/j.pain.2014.09.020.", "ArticleIdList": ["10.1016/j.pain.2014.09.020", "25261162"]}, {"Citation": "Bae E.H., Greenwald M.K., Schwartz A.G. Chemotherapy-Induced Peripheral Neuropathy: Mechanisms and Therapeutic Avenues. Neurotherapeutics. 2021;18:2384\u20132396. doi: 10.1007/s13311-021-01142-2.", "ArticleIdList": ["10.1007/s13311-021-01142-2", "PMC8804039", "34676514"]}, {"Citation": "Loprinzi C.L., Lacchetti C., Bleeker J., Cavaletti G., Chauhan C., Hertz D.L., Kelley M.R., Lavino A., Lustberg M.B., Paice J.A., et al. Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update. J. Clin. Oncol. 2020;38:3325\u20133348. doi: 10.1200/JCO.20.01399.", "ArticleIdList": ["10.1200/JCO.20.01399", "32663120"]}, {"Citation": "Zhang S. Chemotherapy-induced peripheral neuropathy and rehabilitation: A review. Semin. Oncol. 2021;48:193\u2013207. doi: 10.1053/j.seminoncol.2021.09.004.", "ArticleIdList": ["10.1053/j.seminoncol.2021.09.004", "34607709"]}, {"Citation": "Andreyev H.J.N., Wotherspoon A., Denham J.W., Hauer-Jensen M. Defining pelvic-radiation disease for the survivorship era. Lancet Oncol. 2010;11:310\u2013312. doi: 10.1016/S1470-2045(10)70026-7.", "ArticleIdList": ["10.1016/S1470-2045(10)70026-7", "20149738"]}, {"Citation": "Vistad I., Cvancarova M., Kristensen G.B., Foss\u00e5 S.D. A study of chronic pelvic pain after radiotherapy in survivors of locally advanced cervical cancer. J. Cancer Surviv. 2011;5:208\u2013216. doi: 10.1007/s11764-011-0172-z.", "ArticleIdList": ["10.1007/s11764-011-0172-z", "PMC3096775", "21259075"]}, {"Citation": "Markham M.J., Wachter K., Agarwal N., Bertagnolli M.M., Chang S.M., Dale W., Diefenbach C., Rodriguez-Galindo C., George D.J., Gilligan T.D., et al. Clinical Cancer Advances 2020: Annual Report on Progress against Cancer from the American Society of Clinical Oncology. J. Clin. Oncol. 2020;38:1081. doi: 10.1200/JCO.19.03141.", "ArticleIdList": ["10.1200/JCO.19.03141", "32013670"]}, {"Citation": "Clavo B., Rodr\u00edguez-Esparrag\u00f3n F., Rodr\u00edguez-Abreu D., Mart\u00ednez-S\u00e1nchez G., Llontop P., Aguiar-Bujanda D., Fern\u00e1ndez-P\u00e9rez L., Santana-Rodr\u00edguez N. Modulation of Oxidative Stress by Ozone Therapy in the Prevention and Treatment of Chemotherapy-Induced Toxicity: Review and Prospects. Antioxidants. 2019;8:588. doi: 10.3390/antiox8120588.", "ArticleIdList": ["10.3390/antiox8120588", "PMC6943601", "31779159"]}, {"Citation": "Wang K., Tepper J.E. Radiation therapy-associated toxicity: Etiology, management, and prevention. CA Cancer J. Clin. 2021;71:437\u2013454. doi: 10.3322/caac.21689.", "ArticleIdList": ["10.3322/caac.21689", "34255347"]}, {"Citation": "Re L., Martinez-Sanchez G., Bordicchia M., Malcangi G., Pocognoli A., Morales-Segura M.A., Rothchild J., Rojas A. Is ozone pre-conditioning effect linked to Nrf2/EpRE activation pathway in vivo? A preliminary result. Eur. J. Pharm. 2014;742:158\u2013162. doi: 10.1016/j.ejphar.2014.08.029.", "ArticleIdList": ["10.1016/j.ejphar.2014.08.029", "25218903"]}, {"Citation": "Bocci V., Valacchi G. Nrf2 activation as target to implement therapeutic treatments. Front. Chem. 2015;3:4. doi: 10.3389/fchem.2015.00004.", "ArticleIdList": ["10.3389/fchem.2015.00004", "PMC4313773", "25699252"]}, {"Citation": "Gali\u00e8 M., Covi V., Tabaracci G., Malatesta M. The Role of Nrf2 in the Antioxidant Cellular Response to Medical Ozone Exposure. Int. J. Mol. Sci. 2019;20:4009. doi: 10.3390/ijms20164009.", "ArticleIdList": ["10.3390/ijms20164009", "PMC6720777", "31426459"]}, {"Citation": "Viebahn-Haensler R., Fern\u00e1ndez O.L. Ozone in Medicine. The Low-Dose Ozone Concept and Its Basic Biochemical Mechanisms of Action in Chronic Inflammatory Diseases. Int. J. Mol. Sci. 2021;22:7890. doi: 10.3390/ijms22157890.", "ArticleIdList": ["10.3390/ijms22157890", "PMC8346137", "34360655"]}, {"Citation": "Stoker G. The surgical uses of ozone. Lancet. 1917;189:797. doi: 10.1016/S0140-6736(01)49000-3.", "ArticleIdList": ["10.1016/S0140-6736(01)49000-3"]}, {"Citation": "Clavo B., Rodr\u00edguez-Abreu D., Galv\u00e1n S., Federico M., Mart\u00ednez-S\u00e1nchez G., Ramallo-Fari\u00f1a Y., Antonelli C., Ben\u00edtez G., Rey-Baltar D., Jorge I.J., et al. Long-term improvement by ozone treatment in chronic pain secondary to chemotherapy-induced peripheral neuropathy: A preliminary report. Front. Physiol. 2022;13:935269. doi: 10.3389/fphys.2022.935269.", "ArticleIdList": ["10.3389/fphys.2022.935269", "PMC9468657", "36111149"]}, {"Citation": "Clavo B., Navarro M., Federico M., Borrelli E., Jorge I.J., Ribeiro I., Rodr\u00edguez-Melcon J.I., Caram\u00e9s M.A., Santana-Rodr\u00edguez N., Rodr\u00edguez-Esparrag\u00f3n F. Ozone Therapy in Refractory Pelvic Pain Syndromes Secondary to Cancer Treatment: A New Approach Warranting Exploration. J. Palliat. Med. 2021;24:97\u2013102. doi: 10.1089/jpm.2019.0597.", "ArticleIdList": ["10.1089/jpm.2019.0597", "32379556"]}, {"Citation": "Clavo B., Navarro M., Federico M., Borrelli E., Jorge I.J., Ribeiro I., Rodr\u00edguez-Melcon J.I., Caram\u00e9s M.A., Santana-Rodr\u00edguez N., Rodr\u00edguez-Esparrag\u00f3n F. Long-Term Results with Adjuvant Ozone Therapy in the Management of Chronic Pelvic Pain Secondary to Cancer Treatment. Pain Med. 2021;22:2138\u20132141. doi: 10.1093/pm/pnaa459.", "ArticleIdList": ["10.1093/pm/pnaa459", "PMC8557383", "33738491"]}, {"Citation": "Clavo B., Guti\u00e9rrez D., Mart\u00edn D., Su\u00e1rez G., Hern\u00e1ndez M.A., Robaina F. Intravesical Ozone Therapy for Progressive Radiation-Induced Hematuria. J. Altern. Complement. Med. 2005;11:539\u2013541. doi: 10.1089/acm.2005.11.539.", "ArticleIdList": ["10.1089/acm.2005.11.539", "15992242"]}, {"Citation": "Clavo B., Ceballos D., Gutierrez D., Rovira G., Suarez G., Lopez L., Pinar B., Cabezon A., Morales V., Oliva E., et al. Long-Term Control of Refractory Hemorrhagic Radiation Proctitis with Ozone Therapy. J. Pain Symptom Manag. 2013;46:106\u2013112. doi: 10.1016/j.jpainsymman.2012.06.017.", "ArticleIdList": ["10.1016/j.jpainsymman.2012.06.017", "23102757"]}, {"Citation": "Clavo B., Santana-Rodriguez N., Llontop P., Gutierrez D., Ceballos D., M\u00e9ndez C., Rovira G., Suarez G., Rey-Baltar D., Garcia-Cabrera L., et al. Ozone Therapy in the Management of Persistent Radiation-Induced Rectal Bleeding in Prostate Cancer Patients. Evid.-Based Complement. Altern. Med. 2015;2015:480369. doi: 10.1155/2015/480369.", "ArticleIdList": ["10.1155/2015/480369", "PMC4556325", "26357522"]}, {"Citation": "Paquette I.M., Vogel J.D., Abbas M.A., Feingold D.L., Steele S.R. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Treatment of Chronic Radiation Proctitis. Dis. Colon Rectum. 2018;61:1135\u20131140. doi: 10.1097/DCR.0000000000001209.", "ArticleIdList": ["10.1097/DCR.0000000000001209", "30192320"]}, {"Citation": "Herdman M., Gudex C., Lloyd A., Janssen M., Kind P., Parkin D., Bonsel G., Badia X. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) Qual. Life Res. 2011;20:1727\u20131736. doi: 10.1007/s11136-011-9903-x.", "ArticleIdList": ["10.1007/s11136-011-9903-x", "PMC3220807", "21479777"]}, {"Citation": "Ramos-Go\u00f1i J.M., Craig B.M., Oppe M., Ramallo-Fari\u00f1a Y., Pinto-Prades J.L., Luo N., Rivero-Arias O. Handling Data Quality Issues to Estimate the Spanish EQ-5D-5L Value Set Using a Hybrid Interval Regression Approach. Value Health. 2018;21:596\u2013604. doi: 10.1016/j.jval.2017.10.023.", "ArticleIdList": ["10.1016/j.jval.2017.10.023", "29753358"]}, {"Citation": "Emma B. Treatment of advanced non-small-cell lung cancer with oxygen ozone therapy and mistletoe: An integrative approach. Eur. J. Integr. Med. 2012;4:130. doi: 10.1016/j.eujim.2012.07.775.", "ArticleIdList": ["10.1016/j.eujim.2012.07.775"]}, {"Citation": "Tirelli U., Cirrito C., Pavanello M., Del Pup L., Lleshi A., Berretta M. Oxygen-ozone therapy as support and palliative therapy in 50 cancer patients with fatigue\u2014A short report. Eur. Rev. Med. Pharmacol. Sci. 2018;22:8030\u20138033.", "ArticleIdList": ["30536352"]}, {"Citation": "Bennett M.I., Rayment C., Hjermstad M., Aass N., Caraceni A., Kaasa S. Prevalence and aetiology of neuropathic pain in cancer patients: A systematic review. Pain. 2012;153:359\u2013365. doi: 10.1016/j.pain.2011.10.028.", "ArticleIdList": ["10.1016/j.pain.2011.10.028", "22115921"]}, {"Citation": "Mart\u00ednez P., Andreu Y., Gald\u00f3n M.J., Romero R., Garc\u00eda A., Llombart P. Distr\u00e9s emocional y problemas asociados en poblaci\u00f3n oncol\u00f3gica adulta. Psicooncolog\u00eda. 2017;14:217\u2013228. doi: 10.5209/PSIC.57081.", "ArticleIdList": ["10.5209/PSIC.57081"]}, {"Citation": "Mitchell A.J., Chan M., Bhatti H., Halton M., Grassi L., Johansen C., Meader N. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: A meta-analysis of 94 interview-based studies. Lancet Oncol. 2011;12:160\u2013174. doi: 10.1016/S1470-2045(11)70002-X.", "ArticleIdList": ["10.1016/S1470-2045(11)70002-X", "21251875"]}, {"Citation": "DiMatteo M.R., Lepper H.S., Croghan T.W. Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Arch. Intern. Med. 2000;160:2101\u20132107. doi: 10.1001/archinte.160.14.2101.", "ArticleIdList": ["10.1001/archinte.160.14.2101", "10904452"]}, {"Citation": "Batty G.D., Russ T., Stamatakis E., Kivimaki M. Psychological distress in relation to site specific cancer mortality: Pooling of unpublished data from 16 prospective cohort studies. BMJ. 2017;356:j108. doi: 10.1136/bmj.j108.", "ArticleIdList": ["10.1136/bmj.j108", "PMC5266623", "28122812"]}, {"Citation": "Hartung T.J., Friedrich M., Johansen C., Wittchen H.-U., Faller H., Koch U., Br\u00e4hler E., H\u00e4rter M., Keller M., Schulz H., et al. The Hospital Anxiety and Depression Scale (HADS) and the 9-item Patient Health Questionnaire (PHQ-9) as screening instruments for depression in patients with cancer. Cancer. 2017;123:4236\u20134243. doi: 10.1002/cncr.30846.", "ArticleIdList": ["10.1002/cncr.30846", "28654189"]}, {"Citation": "Clavo B., Mart\u00ednez-S\u00e1nchez G., Rodr\u00edguez-Esparrag\u00f3n F., Rodr\u00edguez-Abreu D., Galv\u00e1n S., Aguiar-Bujanda D., D\u00edaz-Garrido J., Ca\u00f1as S., Torres-Mata L., Fabelo H., et al. Modulation by Ozone Therapy of Oxidative Stress in Chemotherapy-Induced Peripheral Neuropathy: The Background for a Randomized Clinical Trial. Int. J. Mol. Sci. 2021;22:2802. doi: 10.3390/ijms22062802.", "ArticleIdList": ["10.3390/ijms22062802", "PMC7998838", "33802143"]}, {"Citation": "Hidalgo-Tall\u00f3n J., Men\u00e9ndez-Cepero S., Vilchez J.S., Rodr\u00edguez-L\u00f3pez C.M., Calandre E.P. Ozone Therapy as Add-On Treatment in Fibromyalgia Management by Rectal Insufflation: An Open-Label Pilot Study. J. Altern. Complement. Med. 2013;19:238\u2013242. doi: 10.1089/acm.2011.0739.", "ArticleIdList": ["10.1089/acm.2011.0739", "23046293"]}, {"Citation": "Li Y., Feng X., Ren H., Huang H., Wang Y., Yu S. Low-Dose Ozone Therapy Improves Sleep Quality in Patients with Insomnia and Coronary Heart Disease by Elevating Serum BDNF and GABA. Bull. Exp. Biol. Med. 2021;170:493\u2013498. doi: 10.1007/s10517-021-05095-6.", "ArticleIdList": ["10.1007/s10517-021-05095-6", "33713235"]}, {"Citation": "Fern\u00e1ndez O.S.L., Viebahn-Haensler R., Cabreja G.L., Espinosa I.S., Matos Y.H., Roche L.D., Santos B.T., Oru G.T., Vega J.C.P. Medical ozone increases methotrexate clinical response and improves cellular redox balance in patients with rheumatoid arthritis. Eur. J. Pharmacol. 2016;789:313\u2013318. doi: 10.1016/j.ejphar.2016.07.031.", "ArticleIdList": ["10.1016/j.ejphar.2016.07.031", "27450487"]}, {"Citation": "Doherty M.K., Leung Y., Su J., Naik H., Patel D., Eng L., Kong Q.Q., Mohsin F., Brown M.C., Espin-Garcia O., et al. Health utility scores from EQ-5D and health-related quality of life in patients with esophageal cancer: A real-world cross-sectional study. Dis. Esophagus. 2018;31:doy058. doi: 10.1093/dote/doy058.", "ArticleIdList": ["10.1093/dote/doy058", "29905764"]}, {"Citation": "Murasawa H., Sugiyama T., Matsuoka Y., Okabe T., Wakumoto Y., Tanaka N., Sugimoto M., Oyama M., Fujimoto K., Horie S., et al. Factors contributing to the ceiling effect of the EQ-5D-5L: An analysis of patients with prostate cancer judged \u201cno-problems\u201d. Qual. Life Res. 2020;29:755\u2013763. doi: 10.1007/s11136-019-02316-4.", "ArticleIdList": ["10.1007/s11136-019-02316-4", "PMC7028791", "31583618"]}, {"Citation": "Davies A., Waylen A., Leary S., Thomas S., Pring M., Janssen B., Beynon R., Lang S., Schimansky S., Hurley K., et al. Assessing the validity of EQ-5D-5L in people with head & neck cancer: Does a generic quality of life measure perform as well as a disease-specific measure in a patient population? Oral Oncol. 2020;101:104504. doi: 10.1016/j.oraloncology.2019.104504.", "ArticleIdList": ["10.1016/j.oraloncology.2019.104504", "31835074"]}, {"Citation": "Homs M.Y., Essink-Bot M.-L., Borsboom G.J., Steyerberg E.W., Siersema P.D. Quality of life after palliative treatment for oesophageal carcinoma\u2014A prospective comparison between stent placement and single dose brachytherapy. Eur. J. Cancer. 2004;40:1862\u20131871. doi: 10.1016/j.ejca.2004.04.021.", "ArticleIdList": ["10.1016/j.ejca.2004.04.021", "15288288"]}, {"Citation": "Young C.J., De-Loyde K.J., Young J.M., Solomon M., Chew E.H., Byrne C.M., Salkeld G., Faragher I.G. Improving Quality of Life for People with Incurable Large-Bowel Obstruction: Randomized Control Trial of Colonic Stent Insertion. Dis. Colon Rectum. 2015;58:838\u2013849. doi: 10.1097/DCR.0000000000000431.", "ArticleIdList": ["10.1097/DCR.0000000000000431", "26252845"]}, {"Citation": "Stoker G. The surgical uses of ozone. Lancet. 1916;188:712. doi: 10.1016/S0140-6736(01)31717-8.", "ArticleIdList": ["10.1016/S0140-6736(01)31717-8"]}, {"Citation": "Viebahn-Hansler R., Leon Fernandez O.S., Fahmy Z. Ozone in Medicine: Clinical Evaluation and Evidence Classification of the Systemic Ozone Applications, Major Autohemotherapy and Rectal Insufflation, According to the Requirements for Evidence-Based Medicine. Ozone-Sci. Eng. 2016;38:322\u2013345. doi: 10.1080/01919512.2016.1191992.", "ArticleIdList": ["10.1080/01919512.2016.1191992"]}, {"Citation": "Hidalgo-Tall\u00f3n F.J., Torres-Morera L.M., Baeza-Noci J., Carrillo-Izquierdo M.D., Pinto-Bonilla R. Updated Review on Ozone Therapy in Pain Medicine. Front. Physiol. 2022;13:840623. doi: 10.3389/fphys.2022.840623.", "ArticleIdList": ["10.3389/fphys.2022.840623", "PMC8904924", "35283802"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "12", "Day": "18"}, {"Year": "2023", "Month": "1", "Day": "5"}, {"Year": "2023", "Month": "1", "Day": "9"}, {"Year": "2023", "Month": "1", "Day": "21", "Hour": "1", "Minute": "23"}, {"Year": "2023", "Month": "1", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "1", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "1", "Day": "13"}], "PublicationStatus": "epublish", "ArticleIdList": ["36674232", "PMC9859304", "10.3390/ijerph20021479", "ijerph20021479"]}}], "PubmedBookArticle": []}